PPARγ and LXR Signaling Inhibit Dendritic Cell-Mediated HIV-1 Capture and -Infection
Dendritic cells (DCs) contribute to human immunodeficiency virus type 1 (HIV-1) transmission and dissemination by capturing and transporting infectious virus from the mucosa to draining lymph nodes, and transferring these virus particles to CD4+ T cells with high efficiency. Toll-like receptor (TLR)-induced maturation of DCs enhances their ability to mediate trans-infection of T cells and their ability to migrate from the site of infection. Because TLR-induced maturation can be inhibited by nuclear receptor (NR) signaling, we hypothesized that ligand-activated NRs could repress DC-mediated HIV-1 transmission and dissemination. Here, we show that ligands for peroxisome proliferator-activated receptor gamma (PPARγ) and liver X receptor (LXR) prevented proinflammatory cytokine production by DCs and inhibited DC migration in response to the chemokine CCL21 by preventing the TLR-induced upregulation of CCR7. Importantly, PPARγ and LXR signaling inhibited both immature and mature DC-mediated trans-infection by preventing the capture of HIV-1 by DCs independent of the viral envelope glycoprotein. PPARγ and LXR signaling induced cholesterol efflux from DCs and led to a decrease in DC-associated cholesterol, which has previously been shown to be required for DC capture of HIV-1. Finally, both cholesterol repletion and the targeted knockdown of the cholesterol transport protein ATP-binding cassette A1 (ABCA1) restored the ability of NR ligand treated cells to capture HIV-1 and transfer it to T cells. Our results suggest that PPARγ and LXR signaling up-regulate ABCA1-mediated cholesterol efflux from DCs and that this accounts for the decreased ability of DCs to capture HIV-1. The ability of NR ligands to repress DC mediated trans-infection, inflammation, and DC migration underscores their potential therapeutic value in inhibiting HIV-1 mucosal transmission.
Vyšlo v časopise:
PPARγ and LXR Signaling Inhibit Dendritic Cell-Mediated HIV-1 Capture and -Infection. PLoS Pathog 6(7): e32767. doi:10.1371/journal.ppat.1000981
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1000981
Souhrn
Dendritic cells (DCs) contribute to human immunodeficiency virus type 1 (HIV-1) transmission and dissemination by capturing and transporting infectious virus from the mucosa to draining lymph nodes, and transferring these virus particles to CD4+ T cells with high efficiency. Toll-like receptor (TLR)-induced maturation of DCs enhances their ability to mediate trans-infection of T cells and their ability to migrate from the site of infection. Because TLR-induced maturation can be inhibited by nuclear receptor (NR) signaling, we hypothesized that ligand-activated NRs could repress DC-mediated HIV-1 transmission and dissemination. Here, we show that ligands for peroxisome proliferator-activated receptor gamma (PPARγ) and liver X receptor (LXR) prevented proinflammatory cytokine production by DCs and inhibited DC migration in response to the chemokine CCL21 by preventing the TLR-induced upregulation of CCR7. Importantly, PPARγ and LXR signaling inhibited both immature and mature DC-mediated trans-infection by preventing the capture of HIV-1 by DCs independent of the viral envelope glycoprotein. PPARγ and LXR signaling induced cholesterol efflux from DCs and led to a decrease in DC-associated cholesterol, which has previously been shown to be required for DC capture of HIV-1. Finally, both cholesterol repletion and the targeted knockdown of the cholesterol transport protein ATP-binding cassette A1 (ABCA1) restored the ability of NR ligand treated cells to capture HIV-1 and transfer it to T cells. Our results suggest that PPARγ and LXR signaling up-regulate ABCA1-mediated cholesterol efflux from DCs and that this accounts for the decreased ability of DCs to capture HIV-1. The ability of NR ligands to repress DC mediated trans-infection, inflammation, and DC migration underscores their potential therapeutic value in inhibiting HIV-1 mucosal transmission.
Zdroje
1. ShattockRJ
MooreJP
2003 Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol 1 25 34
2. GouwsE
WhitePJ
StoverJ
BrownT
2006 Short term estimates of adult HIV incidence by mode of transmission: Kenya and Thailand as examples. Sex Transm Infect 82 Suppl 3 iii51 55
3. PopeM
HaaseAT
2003 Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat Med 9 847 852
4. MillerCJ
LiQ
AbelK
KimEY
MaZM
2005 Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol 79 9217 9227
5. GeijtenbeekTB
KwonDS
TorensmaR
van VlietSJ
van DuijnhovenGC
2000 DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100 587 597
6. HuJ
GardnerMB
MillerCJ
2000 Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J Virol 74 6087 6095
7. FongL
MengozziM
AbbeyNW
HerndierBG
EnglemanEG
2002 Productive infection of plasmacytoid dendritic cells with human immunodeficiency virus type 1 is triggered by CD40 ligation. J Virol 76 11033 11041
8. GuptaP
CollinsKB
RatnerD
WatkinsS
NausGJ
2002 Memory CD4(+) T cells are the earliest detectable human immunodeficiency virus type 1 (HIV-1)-infected cells in the female genital mucosal tissue during HIV-1 transmission in an organ culture system. J Virol 76 9868 9876
9. JamesonB
BaribaudF
PohlmannS
GhavimiD
MortariF
2002 Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J Virol 76 1866 1875
10. PudneyJ
QuayleAJ
AndersonDJ
2005 Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod 73 1253 1263
11. HladikF
SakchalathornP
BallweberL
LentzG
FialkowM
2007 Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26 257 270
12. BomselM
1997 Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat Med 3 42 47
13. BobardtMD
ChatterjiU
SelvarajahS
Van der SchuerenB
DavidG
2007 Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells. J Virol 81 395 405
14. SpiraAI
MarxPA
PattersonBK
MahoneyJ
KoupRA
1996 Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med 183 215 225
15. HuQ
FrankI
WilliamsV
SantosJJ
WattsP
2004 Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. J Exp Med 199 1065 1075
16. BanchereauJ
SteinmanRM
1998 Dendritic cells and the control of immunity. Nature 392 245 252
17. SteinmanRM
Granelli-PipernoA
PopeM
TrumpfhellerC
IgnatiusR
2003 The interaction of immunodeficiency viruses with dendritic cells. Curr Top Microbiol Immunol 276 1 30
18. CameronPU
FreudenthalPS
BarkerJM
GezelterS
InabaK
1992 Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science 257 383 387
19. PopeM
BetjesMG
RomaniN
HirmandH
CameronPU
1994 Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 78 389 398
20. KadowakiN
HoS
AntonenkoS
MalefytRW
KasteleinRA
2001 Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens. J Exp Med 194 863 869
21. PoliG
KinterA
JustementJS
KehrlJH
BresslerP
1990 Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sci U S A 87 782 785
22. PoliG
BresslerP
KinterA
DuhE
TimmerWC
1990 Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. J Exp Med 172 151 158
23. DongC
JanasAM
WangJH
OlsonWJ
WuL
2007 Characterization of human immunodeficiency virus type 1 replication in immature and mature dendritic cells reveals dissociable cis- and trans-infection. J Virol 81 11352 11362
24. WangJH
JanasAM
OlsonWJ
WuL
2007 Functionally distinct transmission of human immunodeficiency virus type 1 mediated by immature and mature dendritic cells. J Virol 81 8933 8943
25. Izquierdo-UserosN
BlancoJ
ErkiziaI
Fernandez-FiguerasMT
BorrasFE
2007 Maturation of blood-derived dendritic cells enhances human immunodeficiency virus type 1 capture and transmission. J Virol 81 7559 7570
26. HarmanAN
WilkinsonJ
ByeCR
BosnjakL
SternJL
2006 HIV induces maturation of monocyte-derived dendritic cells and Langerhans cells. J Immunol 177 7103 7113
27. ShiGX
HarrisonK
HanSB
MoratzC
KehrlJH
2004 Toll-like receptor signaling alters the expression of regulator of G protein signaling proteins in dendritic cells: implications for G protein-coupled receptor signaling. J Immunol 172 5175 5184
28. GlassCK
OgawaS
2006 Combinatorial roles of nuclear receptors in inflammation and immunity. Nat Rev Immunol 6 44 55
29. CastrilloA
TontonozP
2004 Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation. Annu Rev Cell Dev Biol 20 455 480
30. JiangC
TingAT
SeedB
1998 PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 391 82 86
31. RicoteM
LiAC
WillsonTM
KellyCJ
GlassCK
1998 The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391 79 82
32. JosephSB
CastrilloA
LaffitteBA
MangelsdorfDJ
TontonozP
2003 Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 9 213 219
33. CastrilloA
JosephSB
VaidyaSA
HaberlandM
FogelmanAM
2003 Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol Cell 12 805 816
34. OgawaS
LozachJ
BennerC
PascualG
TangiralaRK
2005 Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122 707 721
35. WalcherD
KummelA
KehrleB
BachH
GrubM
2006 LXR activation reduces proinflammatory cytokine expression in human CD4-positive lymphocytes. Arterioscler Thromb Vasc Biol 26 1022 1028
36. AppelS
MirakajV
BringmannA
WeckMM
GrunebachF
2005 PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways. Blood 106 3888 3894
37. PirainoG
CookJA
O'ConnorM
HakePW
BurroughsTJ
2006 Synergistic effect of peroxisome proliferator activated receptor-gamma and liver X receptor-alpha in the regulation of inflammation in macrophages. Shock 26 146 153
38. GhislettiS
HuangW
OgawaS
PascualG
LinME
2007 Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma. Mol Cell 25 57 70
39. ChawlaA
BoisvertWA
LeeCH
LaffitteBA
BarakY
2001 A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell 7 161 171
40. AkiyamaTE
SakaiS
LambertG
NicolCJ
MatsusueK
2002 Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. Mol Cell Biol 22 2607 2619
41. VenkateswaranA
LaffitteBA
JosephSB
MakPA
WilpitzDC
2000 Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc Natl Acad Sci U S A 97 12097 12102
42. LiaoZ
CimakaskyLM
HamptonR
NguyenDH
HildrethJE
2001 Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res Hum Retroviruses 17 1009 1019
43. GuyaderM
KiyokawaE
AbramiL
TurelliP
TronoD
2002 Role for human immunodeficiency virus type 1 membrane cholesterol in viral internalization. J Virol 76 10356 10364
44. GrahamDR
ChertovaE
HilburnJM
ArthurLO
HildrethJE
2003 Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with beta-cyclodextrin inactivates and permeabilizes the virions: evidence for virion-associated lipid rafts. J Virol 77 8237 8248
45. LiaoZ
GrahamDR
HildrethJE
2003 Lipid rafts and HIV pathogenesis: virion-associated cholesterol is required for fusion and infection of susceptible cells. AIDS Res Hum Retroviruses 19 675 687
46. PopikW
AlceTM
2004 CD4 receptor localized to non-raft membrane microdomains supports HIV-1 entry. Identification of a novel raft localization marker in CD4. J Biol Chem 279 704 712
47. NguyenDH
HildrethJE
2000 Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol 74 3264 3272
48. OnoA
FreedEO
2001 Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc Natl Acad Sci U S A 98 13925 13930
49. ManesS
del RealG
LacalleRA
LucasP
Gomez-MoutonC
2000 Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Rep 1 190 196
50. CarterGC
BernstoneL
SanganiD
BeeJW
HarderT
2009 HIV entry in macrophages is dependent on intact lipid rafts. Virology 386 192 202
51. GummuluruS
RogelM
StamatatosL
EmermanM
2003 Binding of human immunodeficiency virus type 1 to immature dendritic cells can occur independently of DC-SIGN and mannose binding C-type lectin receptors via a cholesterol-dependent pathway. J Virol 77 12865 12874
52. GossetP
CharbonnierAS
DeleriveP
FontaineJ
StaelsB
2001 Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells. Eur J Immunol 31 2857 2865
53. StrausDS
GlassCK
2007 Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol 28 551 558
54. SallustoF
SchaerliP
LoetscherP
SchanielC
LenigD
1998 Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 28 2760 2769
55. BaribaudF
DomsRW
PohlmannS
2002 The role of DC-SIGN and DC-SIGNR in HIV and Ebola virus infection: can potential therapeutics block virus transmission and dissemination? Expert Opin Ther Targets 6 423 431
56. WileyRD
GummuluruS
2006 Immature dendritic cell-derived exosomes can mediate HIV-1 trans infection. Proc Natl Acad Sci U S A 103 738 743
57. CavroisM
NeidlemanJ
KreisbergJF
GreeneWC
2007 In vitro derived dendritic cells trans-infect CD4 T cells primarily with surface-bound HIV-1 virions. PLoS Pathog 3 e4
58. TurvilleSG
ArthosJ
DonaldKM
LynchG
NaifH
2001 HIV gp120 receptors on human dendritic cells. Blood 98 2482 2488
59. BashirovaAA
GeijtenbeekTB
van DuijnhovenGC
van VlietSJ
EileringJB
2001 A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J Exp Med 193 671 678
60. PohlmannS
SoilleuxEJ
BaribaudF
LeslieGJ
MorrisLS
2001 DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans. Proc Natl Acad Sci U S A 98 2670 2675
61. NguyenDG
HildrethJE
2003 Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. Eur J Immunol 33 483 493
62. SabadoRL
BabcockE
KavanaghDG
TjomslandV
WalkerBD
2007 Pathways utilized by dendritic cells for binding, uptake, processing and presentation of antigens derived from HIV-1. Eur J Immunol 37 1752 1763
63. PatelM
YanagishitaM
RoderiquezG
Bou-HabibDC
OraveczT
1993 Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res Hum Retroviruses 9 167 174
64. SaphireAC
BobardtMD
ZhangZ
DavidG
GallayPA
2001 Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages. J Virol 75 9187 9200
65. de WitteL
BobardtM
ChatterjiU
DegeestG
DavidG
2007 Syndecan-3 is a dendritic cell-specific attachment receptor for HIV-1. Proc Natl Acad Sci U S A 104 19464 19469
66. BhatS
SpitalnikSL
Gonzalez-ScaranoF
SilberbergDH
1991 Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Proc Natl Acad Sci U S A 88 7131 7134
67. HammacheD
PieroniG
YahiN
DelezayO
KochN
1998 Specific interaction of HIV-1 and HIV-2 surface envelope glycoproteins with monolayers of galactosylceramide and ganglioside GM3. J Biol Chem 273 7967 7971
68. HugP
LinHM
KorteT
XiaoX
DimitrovDS
2000 Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5. J Virol 74 6377 6385
69. PuriA
HugP
JerniganK
BarchiJ
KimHY
1998 The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein. Proc Natl Acad Sci U S A 95 14435 14440
70. NehetePN
VelaEM
HossainMM
SarkarAK
YahiN
2002 A post-CD4-binding step involving interaction of the V3 region of viral gp120 with host cell surface glycosphingolipids is common to entry and infection by diverse HIV-1 strains. Antiviral Res 56 233 251
71. PuigdomenechI
MassanellaM
Izquierdo-UserosN
Ruiz-HernandezR
CurriuM
2008 HIV transfer between CD4 T cells does not require LFA-1 binding to ICAM-1 and is governed by the interaction of HIV envelope glycoprotein with CD4. Retrovirology 5 32
72. HatchSC
ArcherJ
GummuluruS
2009 Glycosphingolipid composition of human immunodeficiency virus type 1 (HIV-1) particles is a crucial determinant for dendritic cell-mediated HIV-1 trans-infection. J Virol 83 3496 3506
73. Izquierdo-UserosN
Naranjo-GomezM
ArcherJ
HatchSC
ErkiziaI
2009 Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway. Blood 113 2732 2741
74. BavariS
BosioCM
WiegandE
RuthelG
WillAB
2002 Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med 195 593 602
75. YonezawaA
CavroisM
GreeneWC
2005 Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha. J Virol 79 918 926
76. PopikW
AlceTM
AuWC
2002 Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells. J Virol 76 4709 4722
77. ChinettiG
LestavelS
BocherV
RemaleyAT
NeveB
2001 PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 7 53 58
78. WasserheitJN
1992 Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 19 61 77
79. RoyceRA
SenaA
CatesWJr
CohenMS
1997 Sexual transmission of HIV. N Engl J Med 336 1072 1078
80. FlemingDT
WasserheitJN
1999 From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 75 3 17
81. HesterRA
KennedySB
2003 Candida infection as a risk factor for HIV transmission. J Womens Health (Larchmt) 12 487 494
82. CelumC
LevineR
WeaverM
WaldA
2004 Genital herpes and human immunodeficiency virus: double trouble. Bull World Health Organ 82 447 453
83. GalvinSR
CohenMS
2004 The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol 2 33 42
84. HaaseAT
2005 Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol 5 783 792
85. WuL
2008 Biology of HIV Mucosal Transmission. Curr Opin HIV AIDS 3 534 540
86. BouschbacherM
BomselM
VerroneseE
GoffloS
GanorY
2008 Early events in HIV transmission through a human reconstructed vaginal mucosa. Aids 22 1257 1266
87. HladikF
McElrathMJ
2008 Setting the stage: host invasion by HIV. Nat Rev Immunol 8 447 457
88. LoreK
SonnerborgA
OlssonJ
PattersonBK
FehnigerTE
1999 HIV-1 exposed dendritic cells show increased pro-inflammatory cytokine production but reduced IL-1ra following lipopolysaccharide stimulation. Aids 13 2013 2021
89. EquilsO
SchitoML
KarahashiH
MadakZ
YaraliA
2003 Toll-like receptor 2 (TLR2) and TLR9 signaling results in HIV-long terminal repeat trans-activation and HIV replication in HIV-1 transgenic mouse spleen cells: implications of simultaneous activation of TLRs on HIV replication. J Immunol 170 5159 5164
90. ZhangJ
LiG
BaficaA
PantelicM
ZhangP
2005 Neisseria gonorrhoeae enhances infection of dendritic cells by HIV type 1. J Immunol 174 7995 8002
91. de JongMA
de WitteL
OudhoffMJ
GringhuisSI
GallayP
2008 TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human Langerhans cells ex vivo. J Clin Invest 118 3440 3452
92. ThibaultS
FromentinR
TardifMR
TremblayMJ
2009 TLR2 and TLR4 triggering exerts contrasting effects with regard to HIV-1 infection of human dendritic cells and subsequent virus transfer to CD4+ T cells. Retrovirology 6 42
93. TurvilleSG
SantosJJ
FrankI
CameronPU
WilkinsonJ
2004 Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 103 2170 2179
94. GarciaE
PionM
Pelchen-MatthewsA
CollinsonL
ArrighiJF
2005 HIV-1 trafficking to the dendritic cell-T-cell infectious synapse uses a pathway of tetraspanin sorting to the immunological synapse. Traffic 6 488 501
95. YuHJ
ReuterMA
McDonaldD
2008 HIV traffics through a specialized, surface-accessible intracellular compartment during trans-infection of T cells by mature dendritic cells. PLoS Pathog 4 e1000134
96. ChunTW
EngelD
MizellSB
EhlerLA
FauciAS
1998 Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines. J Exp Med 188 83 91
97. McGowanI
ElliottJ
FuerstM
TaingP
BoscardinJ
2004 Increased HIV-1 mucosal replication is associated with generalized mucosal cytokine activation. J Acquir Immune Defic Syndr 37 1228 1236
98. NarimatsuR
WoldayD
PattersonBK
2005 IL-8 increases transmission of HIV type 1 in cervical explant tissue. AIDS Res Hum Retroviruses 21 228 233
99. CarrenoMP
KrieffC
IrinopoulouT
KazatchkineMD
BelecL
2002 Enhanced transcytosis of R5-tropic human immunodeficiency virus across tight monolayer of polarized human endometrial cells under pro-inflammatory conditions. Cytokine 20 289 294
100. LaneBR
LoreK
BockPJ
AnderssonJ
CoffeyMJ
2001 Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. J Virol 75 8195 8202
101. del RealG
Jimenez-BarandaS
MiraE
LacalleRA
LucasP
2004 Statins inhibit HIV-1 infection by down-regulating Rho activity. J Exp Med 200 541 547
102. LarredeS
QuinnCM
JessupW
FrisdalE
OlivierM
2009 Stimulation of Cholesterol Efflux by LXR Agonists in Cholesterol-Loaded Human Macrophages Is ABCA1-Dependent but ABCG1-Independent. Arterioscler Thromb Vasc Biol
103. GrootF
WelschS
SattentauQJ
2008 Efficient HIV-1 transmission from macrophages to T cells across transient virological synapses. Blood 111 4660 4663
104. GoussetK
AblanSD
CorenLV
OnoA
SoheilianF
2008 Real-time visualization of HIV-1 GAG trafficking in infected macrophages. PLoS Pathog 4 e1000015
105. JollyC
SattentauQJ
2005 Human immunodeficiency virus type 1 virological synapse formation in T cells requires lipid raft integrity. J Virol 79 12088 12094
106. McDonaldD
WuL
BohksSM
KewalRamaniVN
UnutmazD
2003 Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 300 1295 1297
107. RudnickaD
FeldmannJ
PorrotF
WietgrefeS
GuadagniniS
2009 Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses. J Virol 83 6234 6246
108. ChenP
HubnerW
SpinelliMA
ChenBK
2007 Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses. J Virol 81 12582 12595
109. MorisA
PajotA
BlanchetF
Guivel-BenhassineF
SalcedoM
2006 Dendritic cells and HIV-specific CD4+ T cells: HIV antigen presentation, T-cell activation, and viral transfer. Blood 108 1643 1651
110. Granelli-PipernoA
ShimeliovichI
PackM
TrumpfhellerC
SteinmanRM
2006 HIV-1 selectively infects a subset of nonmaturing BDCA1-positive dendritic cells in human blood. J Immunol 176 991 998
111. BlauveltA
AsadaH
SavilleMW
Klaus-KovtunV
AltmanDJ
1997 Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways. J Clin Invest 100 2043 2053
112. Granelli-PipernoA
DelgadoE
FinkelV
PaxtonW
SteinmanRM
1998 Immature dendritic cells selectively replicate macrophagetropic (M-tropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-tropic virus to T cells. J Virol 72 2733 2737
113. SkolnikPR
RabbiMF
MathysJM
GreenbergAS
2002 Stimulation of peroxisome proliferator-activated receptors alpha and gamma blocks HIV-1 replication and TNFalpha production in acutely infected primary blood cells, chronically infected U1 cells, and alveolar macrophages from HIV-infected subjects. J Acquir Immune Defic Syndr 31 1 10
114. HayesMM
LaneBR
KingSR
MarkovitzDM
CoffeyMJ
2002 Peroxisome proliferator-activated receptor gamma agonists inhibit HIV-1 replication in macrophages by transcriptional and post-transcriptional effects. J Biol Chem 277 16913 16919
115. PotulaR
RamirezSH
KnipeB
LeibhartJ
SchallK
2008 Peroxisome proliferator-activated receptor-gamma activation suppresses HIV-1 replication in an animal model of encephalitis. Aids 22 1539 1549
116. NguyenDH
TaubD
2002 CXCR4 function requires membrane cholesterol: implications for HIV infection. J Immunol 168 4121 4126
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 7
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- RNA Virus Replication Complexes
- Virus-Infection or 5′ppp-RNA Activates Antiviral Signal through Redistribution of IPS-1 Mediated by MFN1
- Functional Genetic Diversity among Complex Clinical Isolates: Delineation of Conserved Core and Lineage-Specific Transcriptomes during Intracellular Survival
- Extreme CD8 T Cell Requirements for Anti-Malarial Liver-Stage Immunity following Immunization with Radiation Attenuated Sporozoites